Adenosine receptors are involved in important cellular processes and adenosine‐derived AR agonists can serve as a platform for the development of therapeutic agents to treat neurogenerative diseases (e.g. Parkinson), cancer, autoimmune inflammation and osteoarthritis. The gene discussed is AR; the disease is cancer.